Compound 531
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)N(=O)=O)c1c2[nH]n(-c2ccc(F)cc2)c1=O
- InChi:
InChI=1S/C20H13FN6O3/c1-25-19-15(10-22-25)18-16(17(23-19)11-3-2-4-14(9-11)27(29)30)20(28)26(24-18)13-7-5-12(21)6-8-13/h2-10,24H,1H3
- InChiKey:
PYLOYQVSTXHVHC-UHFFFAOYSA-N
External links
168318184 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 404.10 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 4.20 | |||
TPSA | 108.87 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4887 | ATX-914 | DB12673 | |
0.4706 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4706 | Riociguat | DB08931 | |
0.4697 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4693 | Dilmapimod | DB12140 | |
0.4646 | Ravoxertinib | DB15281 | |
0.4637 | Merestinib | DB12381 | |
0.4626 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4567 | Risdiplam | DB15305 | |
0.4553 | Vericiguat | DB15456 | |
0.4454 | Neflamapimod | DB07138 | |
0.4421 | Tepotinib | DB15133 | |
0.4386 | Rilematovir | DB15672 | |
0.4380 | Decoglurant | DB11923 | |
0.4348 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DB08054 |